FDA Declines Approval for Two Chinese Cancer Drugs

This is the latest move in the FDA’s increasingly strict stance on approving drugs developed in Asian countries.

May 6, 2022

Getty Images

According to a recent Reuters article, the FDA declined to approve two cancer treatments developed in China. The drugs in question are Hutchmed’s pancreatic cancer treatment and a throat cancer medicine developed by Junshi and Coherus. Single-country trials are responsible for the rejection of the former, while manufacturing issues held up the latter.

Pharmaceutical Traceability & Inspection Innovations Report

Experience a breakthrough in life sciences packaging. Register now!

Your Next FDA Inspection

Claire Lageat, BD Clinical and Human Factors Specialist shared expert insights into how needle choice can impact the self-injection experience.

Improving Self-Injection Delivery of Biologics Through Better Needle Choices

A recent webinar from BD shared important insights into patient fear and anxiety over self-injection and how the right device can ease it.

Through the Line: Packaging and Processing

Through the Line: Patient Centric Autoinjector Pen

Are Take-back Programs The Future of Pharma Packaging or a Miss?

To address the new and evolving regulations within the industry, and streamline packaging development, RegASK recently partnered with Esko, a global leader in integrated software and hardware solutions for packaging and labeling.

How AI Will Help Brands Transform Packaging Compliance and Speed to Market

Through the Line: Advanced Recycling in Medical Packaging

FDA warning letters surge - is your team prepared?

New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.

Medical Device Innovations Report

Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.

Learn More

Products

FDA Declines Approval for Two Chinese Cancer Drugs

Pharmaceutical Traceability & Inspection Innovations Report

Experience a breakthrough in life sciences packaging. Register now!

Your Next FDA Inspection

Improving Self-Injection Delivery of Biologics Through Better Needle Choices

Through the Line: Patient Centric Autoinjector Pen

Are Take-back Programs The Future of Pharma Packaging or a Miss?

How AI Will Help Brands Transform Packaging Compliance and Speed to Market

Through the Line: Advanced Recycling in Medical Packaging

Leak Detection Equipment for Flexible Packaging

Digital Adherence Monitoring Application

Laser-Marked Desiccant Canisters

Spring 2025 Healthcare Packaging

Fall 2024 Healthcare Packaging

Spring 2024 Healthcare Packaging

Winter Healthcare Packaging 2023

Cartoning Innovations Report

Robotics Innovations Report

Avoid FDA warning letters with expert compliance strategies

E-commerce Innovations Report